Develops CBD products for treating conditions including menopause and Alzheimer's disease.
Feb 2026Revenue $124K/yrExpenses $522K/yr
No trend
Figures by year
When will Cannabis Bioscience International Holdings be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Feb 2026, revenue was $124K and expenses $522K.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| May 2025 | $303K | $724K | −$421K |
| May 2024 | $249K | $735K | −$486K |
| May 2023 | $317K | $1.30M | −$983K |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.